Cancer Research

Transforming Cancer Research with Patient-Derived Organoid Innovation
Research & Development Transforming Cancer Research with Patient-Derived Organoid Innovation

Cancer research has entered a new era with the advent of patient-derived organoids (PDOs). These sophisticated three-dimensional (3D) models, grown from patient cells, have revolutionized our understanding of tumors and their microenvironments. By mimicking the complexity of human tumors, PDOs have

AstraZeneca Seeks FDA Approval for EGFR-Mutant NSCLC Therapy
Research & Development AstraZeneca Seeks FDA Approval for EGFR-Mutant NSCLC Therapy

AstraZeneca has recently submitted a Biologics License Application (BLA) to the FDA for datopotamab deruxtecan (Dato-DXd), targeting accelerated approval for adults with locally advanced or metastatic non-small cell lung cancer (NSCLC) that possess EGFR mutations. This submission is a significant

Early CGP Testing Improves Cancer Treatment and Patient Survival Rates
Research & Development Early CGP Testing Improves Cancer Treatment and Patient Survival Rates

Comprehensive Genomic Profiling (CGP) is revolutionizing cancer treatment by enabling early detection and personalized therapy. A recent study published in the Journal of Clinical Oncology - Oncology Practice (JCO-OP) highlights the significant benefits of early CGP testing in improving clinical

Overcoming Life After Cancer: Challenges and Support for Young Survivors
Research & Development Overcoming Life After Cancer: Challenges and Support for Young Survivors

Advancements in cancer diagnosis and treatment have significantly improved survival rates, leading to a growing number of young cancer survivors. This demographic shift brings unique challenges as these individuals navigate life post-treatment, facing physical, emotional, and social upheavals. The

Rising Breast Cancer Rates Among Indian Women Aged 55-64 Demand Action
Research & Development Rising Breast Cancer Rates Among Indian Women Aged 55-64 Demand Action

Breast Cancer Awareness Month has highlighted a pressing health crisis among Indian women, particularly those aged 55 to 64. A recent report by Healthians reveals that 16% of women in this demographic are affected by breast cancer. This alarming statistic underscores the urgent need for awareness,

FDA Approves Aucatzyl, a New CAR-T Therapy to Rival Tecartus
Research & Development FDA Approves Aucatzyl, a New CAR-T Therapy to Rival Tecartus

The recent approval of Aucatzyl by the FDA marks a significant advancement in the treatment landscape for patients with B-cell precursor acute lymphoblastic leukemia, especially those whose disease has progressed following initial chemotherapy treatments. Developed by U.K.-based Autolus

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later